APA Zitierstil

de Miranda Santos, I. K. F., & de Barros Cardoso, C. R. (2021). Commentary on "Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy" by D.C. Mastellos et al. Clinical immunology (Orlando, Fla.), 222, 108618. https://doi.org/10.1016/j.clim.2020.108618

Chicago Zitierstil

de Miranda Santos, Isabel Kinney Ferreira, und Cristina Ribeiro de Barros Cardoso. "Commentary on "Complement C3 Vs C5 Inhibition in Severe COVID-19: Early Clinical Findings Reveal Differential Biological Efficacy" by D.C. Mastellos Et Al." Clinical Immunology (Orlando, Fla.) 222 (2021): 108618. https://dx.doi.org/10.1016/j.clim.2020.108618.

MLA Zitierstil

de Miranda Santos, Isabel Kinney Ferreira, und Cristina Ribeiro de Barros Cardoso. "Commentary on "Complement C3 Vs C5 Inhibition in Severe COVID-19: Early Clinical Findings Reveal Differential Biological Efficacy" by D.C. Mastellos Et Al." Clinical Immunology (Orlando, Fla.), vol. 222, 2021, p. 108618.